Comparative Efficacy of Oral Nucleoside or Nucleotide Analog Monotherapy Used in Chronic Hepatitis B: A Mixed-Treatment Comparison Meta-analysis
Author:
Affiliation:
1. Department of Pharmacy; Pharmacy Practice Research Group; Federal University of Paraná; Curitiba Brazil
2. Department of Medical Pathology; Federal University of Paraná; Curitiba Brazil
Publisher
Wiley
Subject
Pharmacology (medical)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1188/fullpdf
Reference21 articles.
1. Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides;Nguyen;J Viral Hepat,2009
2. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update;Keeffe;Clin Gastroenterol Hepatol,2008
3. Chronic hepatitis B;Lok;Hepatology,2007
4. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B;Marcellin;N Engl J Med,2004
5. European guideline for the management of hepatitis B and C virus infections;Brook;Int J STD AIDS,2010
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. OCRELIZUMAB THERAPY IN PATIENTS WITH ANTI-HBC ANTIBODIES – A PRELIMINARY STUDY;Polski Merkuriusz Lekarski;2023
2. Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study;Hepatology International;2022-06-14
3. Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study;Journal of Viral Hepatitis;2021-08-11
4. Tenofovir is Superior to Entecavir in Patients with Treatment-naïve Hepatitis B e-Antigen–Positive Chronic Hepatitis B;Journal of Clinical and Experimental Hepatology;2021-01
5. Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment;Journal of Viral Hepatitis;2020-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3